FDA Proposes Cutting Nicotine Amounts In Cigarettes, Targeting Addiction
It would be the first time in the agency's history that it has sought to regulate the amount of nicotine in cigarettes.
The innovative drug Ocrevus looks as if it could be a game-changer for people with MS. But it's very, very expensive. And as with any new medication, the long-term safety risks are unknown.